维生素K对2型糖尿病作用机制的研究进展

Abstract
Figure/Table
References (31)
Related Citation (15)

Download: PDF (498 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Type 2 diabetes mellitus is one of the major chronic diseases of global concern. Its pathogenesis has not yet been fully elucidated. It is a worldwide public health problem threatening human health. Vitamin K is a kind of naphthoquinone derivative with phylloquinone biological activity. It is a biologically active compound necessary to maintain optimal body function. It can participate in the carboxylation process of Vitamin K dependent proteins, it plays a positive role in prerenting and treating atherosclerosis, reducing the release of inflammatory factors, and improving insulin sensitivity have a positive effect. This review focuses on the possible mechanism of Vitamin K in regulating insulin sensitivity and blood sugar status, adding new adjuvant treatments to better control the progress of diabetes.

Key words： Vitamin K Type 2 diabetes mellitus Insulin resistance Vitamin K dependent protein Inflammatory factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Anran LIU XiuXiang

Cite this article:

GUO Anran LIU XiuXiang. Study progress on the mechanism of Vitamin K on type 2 diabetes mellitus[J]. 中国医药导报, 2022, 19(16): 34-37.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I16/34

[1] Saeedi P，Petersohn I，Salpea P，et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045：Results from the International Diabetes Federation Diabetes Atlas，9th edition [J]. Diabetes Res Clin Pract，2019，157：107843.
[2] Azuma K，Inoue S. Multiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders [J]. Int J Mol Sci，2019，20（11）：2844.
[3] Tarento TDC，McClure DD，Talbot AM，et al. A potential biotechnological process for the sustainable production of vitamin K1 [J]. Crit Rev Biotechnol，2019，39（1）：1-19.
[4] Zwakenberg SR，Remmelzwaal S，Beulens JWJ，et al. Circulating Phylloquinone Concentrations and Risk of Type 2 Diabetes：A Mendelian Randomization Study [J]. Diabetes，2019，68（1）：220-225.
[5] Fusaro M，Gallieni M，Porta C，et al. Vitamin K effects in human health：new insights beyond bone and cardiovascular health [J]. J Nephrol，2020，33（2）：239-249.
[6] Bjornebye Vik A. Vitamin K2 and arterial calcification [J]. Agro Food Industry Hi-Tech，2009，19（6）：9-13.
[7] Villa JKD，Diaz MAN，Pizziolo VR，et al. Effect of vitamin K in bone metabolism and vascular calcification：A review of mechanisms of action and evidences [J]. Crit Rev Food Sci Nutr，2017，57（18）：3959-3970.
[8] Lee NK，Sowa H，Hinoi E，et al. Endocrine regulation of energy metabolism by the skeleton [J]. Cell，2007，130（3）：456-469.
[9] Moser SC，van der Eerden BCJ. Osteocalcin-A Versatile Bone-Derived Hormone [J]. Front Endocrinol （Lausanne），2019，9：794.
[10] Ferron M，Hinoi E，Karsenty G，et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice [J]. Proc Natl Acad Sci U S A，2008，105（13）：5266-5270.
[11] Razny U，Fedak D，Kiec-Wilk B，et al. Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes [J]. Diabetes Metab Res Rev，2017，33（3）：e2862.
[12] Roumeliotis S，Dounousi E，Eleftheriadis T，et al. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake，Calcification，Mortality，and Cardiovascular Disease：A Review [J]. Int J Mol Sci，2019，20（3）：628.
[13] Antonopoulos S，Mylonopoulou M，Angelidi AM，et al. Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and Lp（a） in diabetes：A cross-sectional study [J]. Diabetes Res Clin Pract，2017， 130：252-257.
[14] Li YH，Lu CH，Lin FH，et al. Plasma Growth Arrest-Specific 6 Protein and Genetic Variations in the GAS6 Gene in Patients with Metabolic Syndrome [J]. Metab Syndr Relat Disord，2019，17（1）：22-28.
[15] Hung YJ，Lee CH，Chu NF，et al. Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance，inflammation，and endothelial dysfunction [J]. Diabetes Care，2010，33（8）：1840-1844.
[16] Lee CH，Chu NF，Shieh YS，et al. The growth arrest-specific 6 （Gas6） gene polymorphism c.834+7G>A is associated with type 2 diabetes [J]. Diabetes Res Clin Pract，2012，95（2）：201-206.
[17] 范梅琳.血清Gas6水平与2型糖尿病的相关型研究[J].健康必读，2021（6）：37.
[18] 陈玲，成兴波.2型糖尿病患者血清生长停滞特异性基因产物6水平的变化及相关因素分析[J].中国糖尿病杂志，2013，21（8）：721-723.
[19] Luo J，Qi J，Wang W，et al. Antiobesity Effect of Flaxseed Polysaccharide via Inducing Satiety due to Leptin Resistance Removal and Promoting Lipid Metabolism through the AMP-Activated Protein Kinase （AMPK） Signaling Pathway [J]. J Agric Food Chem，2019，67（25）：7040-7049.
[20] Knapen MHJ，Jardon KM，Vermeer C. Vitamin K-induced effects on body fat and weight：results from a 3-year vitamin K2 intervention study [J]. Eur J Clin Nutr，2018，72（1）：136-141.
[21] Wang Y，Wang X，Lau WB，et al. Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation [J]. Circ Res，2014，114（5）：792-805.
[22] Marilyn L，Marie-Claude B，Myriam D，et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus [J]. Diabetes Care，2013，36（6）：1577-1583.
[23] Xu J，Zhao YH，Chen YP，et al. Maternal circulating concentrations of tumor necrosis factor-alpha，leptin，and adiponectin in gestational diabetes mellitus：a systematic review and meta-analysis [J]. Scientific World Journal，2014，2014：926932.
[24] Stefan N. Causes，consequences，and treatment of metabolically unhealthy fat distribution [J]. Lancet Diabetes Endocrinol，2020，8（7）：616-627.
[25] 周聪，高峰，张皎月，等.肿瘤坏死因子α转化酶在IR中的作用及有关机制[J].中西医结合研究，2019，11（5）：270-272，275.
[26] Mohamad HE，Asker ME，Keshawy MM，et al. Infliximab ameliorates tumor necrosis factor-alpha exacerbated renal insulin resistance induced in rats by regulating insulin signaling pathway [J]. Eur J Pharmacol，2020，872：172959.
[27] 陈袁，赵倩，康琪，等.脂蛋白（ａ）、超敏Ｃ反应蛋白表达水平与IR的相关性研究[J].中国现代医学杂志，2019， 29（6）：39-42．
[28] Ceki■ S，Cvetkovi■ T，Jovanovi■ I，et al. C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy [J]. Bosn J Basic Med Sci，2014，14（3）：177-184.
[29] Harding JL，Pavkov ME，Magliano DJ，et al. Global trends in diabetes complications：a review of current evidence [J]. Diabetologia，2019，62（1）：3-16.
[30] Jaminon AMG，Dai L，Qureshi AR，et al. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease [J]. Sci Rep，2020，10（1）：6586.
[31] Miyata KN，Nast CC，Dai T，et al. Renal matrix Gla protein expression increases progressively with CKD and predicts renal outcome [J]. Exp Mol Pathol，2018，105（1）：120-129.